BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7727847)

  • 1. Chronic recurrent acyclovir-resistant genital herpes in an immunocompetent patient.
    Mouly F; Baccard M; Scieux C; Schnell L; Locq-Ebner S; Morinet F; Morel P
    Dermatology; 1995; 190(2):177. PubMed ID: 7727847
    [No Abstract]   [Full Text] [Related]  

  • 2. Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient.
    Kost RG; Hill EL; Tigges M; Straus SE
    N Engl J Med; 1993 Dec; 329(24):1777-82. PubMed ID: 8232486
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-healing genital herpes mimicking donovanosis in an immunocompetent man.
    Gupta V; Khute P; Patel A; Gupta S
    Int J STD AIDS; 2016 Jan; 27(1):72-4. PubMed ID: 25614521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic vulvar ulceration in an immunocompetent woman due to acyclovir-resistant, thymidine kinase-deficient herpes simplex virus.
    Swetter SM; Hill EL; Kern ER; Koelle DM; Posavad CM; Lawrence W; Safrin S
    J Infect Dis; 1998 Mar; 177(3):543-50. PubMed ID: 9498430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.
    Wald A; Corey L; Cone R; Hobson A; Davis G; Zeh J
    J Clin Invest; 1997 Mar; 99(5):1092-7. PubMed ID: 9062368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of long-term, low-dose acyclovir suppressive therapy on susceptibility to acyclovir and frequency of acyclovir resistance of herpes simplex virus type 2.
    Honda M; Okuda T; Hasegawa T; Kurokawa M; Shiraki K; Matsuo K; Komatsuzaki M; Niimura M
    Antivir Chem Chemother; 2001 Jul; 12(4):233-9. PubMed ID: 11771732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis.
    Pechère M; Wunderli W; Trellu-Toutous L; Harms M; Saura JH; Krischer J
    Dermatology; 1998; 197(3):278-80. PubMed ID: 9812037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic vulvar herpes].
    Dehen L; Vilmer C
    Ann Dermatol Venereol; 2006 Mar; 133(3):296-7. PubMed ID: 16800190
    [No Abstract]   [Full Text] [Related]  

  • 9. [Guidelines (brief text): management of cutaneo-mucosal herpes in the immunocompetent patient (ocular manifestations excluded)].
    J Gynecol Obstet Biol Reprod (Paris); 2003 Feb; 32(1):58-67. PubMed ID: 12592186
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of topical acyclovir monophosphate, acyclovir, or penciclovir in orofacial HSV-1 infections of mice and genital HSV-2 infections of guinea pigs.
    Kern ER; Palmer J; Szczech G; Painter G; Hostetler KY
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):501-13. PubMed ID: 10772730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fulminant, acyclovir-resistant, herpes simplex virus type 2 hepatitis in an immunocompetent woman.
    Czartoski T; Liu C; Koelle DM; Schmechel S; Kalus A; Wald A
    J Clin Microbiol; 2006 Apr; 44(4):1584-6. PubMed ID: 16597901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genital ulcers associated with acute Epstein-Barr virus infection.
    Taylor S; Drake SM; Dedicoat M; Wood MJ
    Sex Transm Infect; 1998 Aug; 74(4):296-7. PubMed ID: 9924475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneomucosal herpes in immunocompetent pregnant women].
    Lecat M
    Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):523-32. PubMed ID: 12122322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
    Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
    Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes vegetans of the vulva.
    Abril-Pérez C; Roca-Ginés J; Sánchez-Arráez J; Torres-Navarro I; Botella-Estrada R
    Am J Obstet Gynecol; 2021 Nov; 225(5):570-571. PubMed ID: 34051164
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term suppressive therapy with acyclovir for recurrent genital herpes.
    Baker DA
    J Int Med Res; 1994; 22 Suppl 1():24A-31A; discussion 31A-32A. PubMed ID: 8063021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.
    Wald A; Carrell D; Remington M; Kexel E; Zeh J; Corey L
    Clin Infect Dis; 2002 Apr; 34(7):944-8. PubMed ID: 11880960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
    Tyring SK; Baker D; Snowden W
    J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hypertrophic acyclovir-resistant genital herpes treated with topical cidofovir and with topical foscarnet at recurrence in an HIV-positive man.
    Ghislanzoni M; Cusini M; Zerboni R; Alessi E
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):887-9. PubMed ID: 16898926
    [No Abstract]   [Full Text] [Related]  

  • 20. Genital herpes due to acyclovir-sensitive herpes simplex virus caused secondary and recurrent herpetic whitlows due to thymidine kinase-deficient/temperature-sensitive virus.
    Shimada Y; Suzuki M; Shirasaki F; Saito E; Sogo K; Hasegawa M; Takehara K; Phromjai J; Chuhjo T; Shiraki K
    J Med Virol; 2007 Nov; 79(11):1731-40. PubMed ID: 17854045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.